In the context of CNS disorders, AIF1 has also been recognized as a marker of microglial and monocyte activation, particularly in meningoencephalitis models [58,59], emphasizing its significance in immune modulation within the brain. The gene discussed is AIF1; the disease is central nervous system disorder.